Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Medical News

Only North American MDR-TB Drug Maker Closing After Five Years

April 27, 2010

An Indiana-based manufacturer of a treatment for multi-drug resistant tuberculosis is closing, the Associated Press/Indianapolis Business Journal reports. "The Purdue Research Foundation says the Chao Center for Industrial Pharmacy and Contract Manufacturing was unable to become self-sustaining in part because of the recession. The center ... reached an agreement with Eli Lilly and Co. in 2007 to become North America's sole maker of the tuberculosis drug Seromycin" (4/27).

Back to other news for April 2010


This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 
See Also
Tuberculosis (TB) Fact Sheet
Questions and Answers About Tuberculosis
More News on Tuberculosis and HIV/AIDS
Advertisement:
Find out how a Walgreens specially trained pharmacist can help you

Tools
 

Advertisement